Search the Newsreel

Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma

Bristol Myers Squibb's drug, iberdomide (Zenbexus), has received accelerated FDA approval for treating multiple myeloma, making it the first FDA-approved cereblon-modulating (CELMoD) protein degrader. Zenbexus is indicated for use with Darzalex Faspro and dexamethasone in adults who have received at least one prior line …

Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Bristol Myers Squibb (BMY) is back in focus after the FDA granted accelerated approval for ZENBEXUS in a multiple myeloma combination regimen, introducing …

Seth Klarman Just Quietly Bought a Piece of Bill Ackman’s Firm

Quick Read Seth Klarman's Baupost Group bought 392,000 shares of Pershing Square (PS), placing roughly $13 million behind Ackman's Berkshire-style listed management company pitch. PS shares climbed 17% before Baupost's filing disclosed the position, and only 3 of 10 analysts rate it a buy …

Pershing Square (NYSE:PS) Shares Down 6.9% - What's Next?

Z Squared CEO to Shareholders: "The Scarcest Thing in AI Is Not Chips. It Is Power."

The CEO of Z Squared, an investment firm, communicated to shareholders that the primary bottleneck for artificial intelligence development is not the availability of chips, but rather the access to sufficient power. This highlights a critical and often overlooked infrastructure challenge for the rapidly …

Pershing Square Ord Shs Stock (PS) Moved Down by 7.46% on Aug 14: What Signal Does It Send?

Block's Square Backs The Baked Bear: Will Franchise Growth Accelerate?

Block's XYZ Square is strengthening its presence in the food and beverage industry as The Baked Bear, a handcrafted cookie ice cream sandwich brand, expands its national footprint. The dessert chain currently operates 36 U.S. locations and plans to add at least five more …

Bristol Myers Squibb stock gains support from new multiple myeloma approval and raised earnings fore

Madison Square Garden (NYSE:MSGS) Price Target Raised to $477.00

Die Bristol-Myers-Squibb-Aktie profitiert von FDA-Zulassung und solider Prognose

T. Rowe Price Investment Management (MSGS) discloses 5.6% ownership in Madison Square Garden Sports

T. Rowe Price Investment Management has reported a 5.6% beneficial ownership stake in Madison Square Garden Sports Corp. (MSGS), totaling 1,096,758 shares. The firm holds sole voting power over 1,074,218 shares and sole dispositive power over all 1,096,758 shares, as detailed in a Schedule …

Madison Square Garden Ent. (MSGE) stake at 13.1% held by Ariel

Ariel Investments, LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 5,302,754 shares of Madison Square Garden Entertainment Corp (MSGE) Class A common stock, representing 13.1% of the class as of June 30, 2026. Ariel holds sole voting power over 4,728,858 …

Madison Square Garden (NYSE:MSGS) Stock Price Expected to Rise, Guggenheim Analyst Says

Z Squared targets 100 MW AI-ready power capacity via acquisitions, focusing on power-first strategy and disciplined scaling.

Z Squared Inc. aims to achieve 100 megawatts of AI-ready power capacity in the U.S. through strategic acquisitions of power-rich, grid-connected sites, starting with Paradox Data's Union County campus in Arkansas. The company plans to fund its expansion through stock issuance without incurring debt, …

ESQ|Esquire Financial Holdings Inc|Price:132.200|

Townsquare Media (TSQ) stake of 824,004 shares disclosed in 13G/A

American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research have filed an amended 13G/A report disclosing a beneficial ownership of 824,004 shares of Townsquare Media (TSQ) Class A Common Stock, representing 4.9% of the class. The group …

Z Squared outlines power-first AI infrastructure strategy By Investing.com

Z Squared Inc. has announced a strategic shift towards acquiring power-connected sites to convert into AI infrastructure. The company recently signed an agreement to acquire Paradox Data and its Union County campus, which already has 8 megawatts of energized capacity and aims for up …

Palmer Square Capital BDC Inc (PSBD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Palmer Square Capital BDC Inc (PSBD), detailing its current price momentum score, support and resistance levels, and a summary of various technical indicators and moving averages. As of the report, PSBD has a momentum score of 3.31 …

Csquare, Inc. Actuals & Estimates (NYSE:CSQR)

Die Bristol-Myers-Squibb-Aktie legt nach starken Q2-Zahlen und neuer Zahlung zu

BMS welcomes new multiple myeloma drug as generics batter current portfolio

Bristol Myers Squibb (BMS) received accelerated FDA approval for Zenbexus (iberdomide) for multiple myeloma, offering a new revenue stream as generics severely impact sales of its existing drugs, Revlimid and Pomalyst. Zenbexus is projected to achieve over $1 billion in annual earnings by 2031, …

Oksenholt Capital Challenges Pershing Square’s Discounted Freddie Mac Valuation

The same business deserves the same multiple. On the evidence, Freddie may deserve more. SCOTTSDALE, Ariz., August 14, 2026--(BUSINESS WIRE)--Oksenholt Capital Management LLC today released a valuation analysis challenging Pershing Square's decision to value Freddie Mac (FMCC) at a materially lower earnings multiple than …

BTIG raises Madison Square Garden Entertainment stock price target on strong earnings

Bristol Myers Squibb announces new $2.3bn campus in the US

Bristol Myers Squibb has announced a new $2.3 billion multi-modal manufacturing campus in Houston, Texas, creating nearly 500 skilled jobs. This investment is part of BMS's $40 billion commitment to the US, aiming to accelerate the delivery of next-generation medicines. The campus's modular design …

Pershing Square Stock: A More Expensive Way To Bet With Bill Ackman Than HHH Or PSUS

GameSquare Holds 15,080 ETH, Discloses $25.9M in Total Assets

Nasdaq-listed media and entertainment company GameSquare (GAME) announced it held 15,080 Ethereum (ETH) as of June 30, with total assets amounting to approximately $25.9 million, including ETH, other altcoins, and cash. This disclosure highlights a growing trend of public companies investing in digital assets …

Madison Square Garden Q4 Earnings Call Highlights

This article first appeared on GuruFocus. Total Revenues (FY2026): Approximately $1.2 billion. Adjusted Operating Income (FY2026): Nearly $59 million. Total Revenues (Q4 FY2026): $278.7 million, up from $204 million in the prior year period. Event-Related Revenues (Q4 FY2026): $200.7 million, an increase of 43% …

How Investors Are Reacting To Intercontinental Exchange (ICE) Pershing Stake And Bond Issuance Momentum

In August 2026, Intercontinental Exchange, Inc. completed several fixed-income offerings totaling about US$3.73 billion in callable senior unsecured and subordinated notes with fixed coupons, alongside reporting strong July trading volumes and open interest across key asset classes. The disclosure that Pershing Square has built …

Madison Square Garden Entertainment (MSGE) Stock Price Resets As Valuation Draws Focus

Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?

Key Points Earlier this month, AstraZeneca and Bristol Myers Squibb became the subject of merger rumors. Investors reacted negatively to the rumors, even if on paper such a deal would create an oncology-focused big pharma powerhouse worth around $400 billion. Considering regulatory uncertainty and …

Pershing Square H1 2026 Letter To Shareholders

Barclays PLC discloses 1,837,155-share MSGE stake in Madison Square Garden Entert (MSGE)

Barclays PLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 1,837,155 shares in Madison Square Garden Entertainment Corp. (MSGE), which represents 4.54% of the class. The filing specifies that Barclays PLC holds sole voting and dispositive power over 1,815,732 shares, and …

Coeptis Therapeutics (NASDAQ:ZSQR) Issues Quarterly Earnings Results

Madison Square Garden Sports Submits 10-K for Fiscal 2026 Detailing Potential Rangers and Knicks Spin-Off

Madison Square Garden Sports Corp. filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2026, outlining plans for a potential spin-off to separate the New York Rangers and New York Knicks into two independent publicly traded companies. The board …

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

Bristol Myers Squibb announced that the U.S. FDA has granted accelerated approval for ZENBEXUS™ (iberdomide) in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd) for adult patients with multiple myeloma who have received at least one prior line of therapy. This approval, based on …

Pershing Square Inc. (PS) swings to $190M loss while assets reach $1.8B